BioChem Pharma Inc.
62Patents
0Active
62Granted
36Portfolio score
Filing activity: Jun 30, 1989 → Feb 24, 2003
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5466806A | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties | Chemistry; Metallurgy | 86 | Expired |
| US5312899A | Dermorphin analogs | Human Necessities | 85 | Expired |
| US5270315A | 4-(purinyl bases)-substituted-1,3-dioxlanes | Chemistry; Metallurgy | 75 | Expired |
| US6784161B2 | Method for the treatment or prevention of flavivirus infections using nucleoside analogues | Human Necessities | 67 | Expired |
| US6566365B1 | Method for the treatment of Flaviviridea viral infection using nucleoside analogues | Human Necessities | 53 | Expired |
| US6274620A | Thiophene integrin inhibitors | Chemistry; Metallurgy | 53 | Expired |
| US5538975A | 1,3-oxathiolane nucleoside compounds and compositions | Chemistry; Metallurgy | 53 | Expired |
| US5756706A | Processes for the diastereoselective synthesis of nucleoside analogues | Chemistry; Metallurgy | 52 | Expired |
| US5696254A | Processes for the diastereoselective synthesis of nucleoside analogues | Chemistry; Metallurgy | 51 | Expired |
| US5486520A | 1,3-oxathiolanes useful in the treatment of hepatitis | Human Necessities | 48 | Expired |
| US5151426A | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties | Chemistry; Metallurgy | 42 | Expired |
| US6340690B1 | Antiviral methods using [1,8]naphthyridine derivatives | Human Necessities | 42 | Expired |
| US5618820A | 1,3-oxathiolane nucleoside analogues and methods for using same | Chemistry; Metallurgy | 42 | Expired |
| US5684164A | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties | Chemistry; Metallurgy | 39 | Expired |
| US5587480A | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties | Chemistry; Metallurgy | 36 | Expired |
| US6444656B1 | Antiviral phosphonate nucleotides | Chemistry; Metallurgy | 34 | Expired |
| US5955610A | Antiviral compounds | Chemistry; Metallurgy | 32 | Expired |
| US6005107A | Antiviral compounds | Chemistry; Metallurgy | 30 | Expired |
| US5994361A | Substituted purinyl derivatives with immunomodulating activity | Human Necessities | 29 | Expired |
| US5744596A | Nucleoside analogues and synthetic intermediates | Chemistry; Metallurgy | 27 | Expired |
| US6350753B1 | 2-Substituted-4-substituted-1,3-dioxolanes and use thereof | Chemistry; Metallurgy | 27 | Expired |
| US6110923A | Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity | Human Necessities | 26 | Expired |
| US5532246A | Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B | Human Necessities | 26 | Expired |
| US6605614B2 | [1,8] naphthyridine derivatives having antiviral activity | Human Necessities | 26 | Expired |
| US6630488B1 | Quinolizinones as integrin inhibitors | Chemistry; Metallurgy | 26 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.